Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Packham
Effect of Bardoxolone Methyl on the Urine Albumin-To-Creatinine Ratio in Patients With Type 2 Diabetes and Stage 4 Chronic Kidney Disease.
Kidney International
Nephrology
Related publications
Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-To-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality
JAMA - Journal of the American Medical Association
Medicine
The Longitudinal Effect of Subclinical Hypothyroidism on Urine Microalbumin-To-Urine Creatinine Ratio in Patients With Type 2 Diabetes Mellitus
BMC Endocrine Disorders
Medicine
Endocrinology
Metabolism
Diabetes
Cardiac and Renal Function in Patients With Type 2 Diabetes Who Have Chronic Kidney Disease: Potential Effects of Bardoxolone Methyl
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Bardoxolone Methyl and Kidney Function in CKD With Type 2 Diabetes
New England Journal of Medicine
Medicine
Correlation Between Albumin Creatinine Ratio and Hypertension in Type 2 Diabetes
JHeS (Journal of Health Studies)
Effect of Alogliptin on Hypertensive Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
Australasian Medical Journal
Medicine
Inсretin-Based Therapy in Patients With Type 2 Diabetes and Chronic Kidney Disease
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Reno-Protective Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blockers in Type 2 Diabetic Nephropathy With Elevated Urine Albumin to Creatinine Ratio
International Journal of Advances in Medicine
Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Medical News of North Caucasus
Medicine
